Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease

Mucosal Immunology

Volumn 6, Issue 6, 2013, Pages 1202-1213

  Van Leeuwen, M A ^a   Lindenbergh Kortleve, D J ^a   Raatgeep, H C ^a   De Ruiter, L F ^a   De Krijger, R R ^b,d   Groeneweg, M ^c   Escher, J C ^a   Samsom, J N ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Maasstad Hospital ^*  (Netherlands)

^d REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 21; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3;

ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELL COUNT; CELLULAR SECRETION; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUODENUM INJURY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INTESTINE BIOPSY; LAMINA PROPRIA; LYMPHOCYTE; NEUTROPHIL; PEDIATRICS; POLYCLONAL ACTIVATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUORUM SENSING; SCHOOL CHILD; SMALL INTESTINE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; CELL SEPARATION; CELLS, CULTURED; CHILD; DISEASE PROGRESSION; FLOW CYTOMETRY; GLUTENS; HUMANS; INTERLEUKIN-17; INTERLEUKINS; INTESTINE, SMALL; LYMPHOCYTE ACTIVATION; MUCOUS MEMBRANE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; UP-REGULATION;

EID: 84886082042     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.19     Document Type: Article

References (34)

1. Green, P.H. & Cellier, C. Celiac disease. N. Engl. J. Med. 357, 1731-1743 (2007).
2. Nilsen, E.M. et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115, 551-563 (1998).
3. Fina, D. et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57, 887-892 (2008).
4. van Heel, D.A. et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39, 827-829 (2007).
5. Parrish-Novak, J., Dillon, S.R., Nelson, A., Hammond, A., Sprecher, C. & Gross, J.A. et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57-63 (2000).
6. Coquet, J.M. et al. IL-21 is produced by NKTcells and modulates NKTcell activation and cytokine production. J. Immunol. 178, 2827-2834 (2007).
7. Puga, I. et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13, 170-180 (2012).
8. Sarra,M. et al. IL-15 positively regulates IL-21 production in celiac disease mucosa. Mucosal. Immunol. 6, 244-255 (2012).
9. Bodd, M. et al. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal. Immunol. 3, 594-601 (2011).
10. Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007).
11. Peluso, I. et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J. Immunol. 178, 732-739 (2007).
12. Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
13. Park, H. et al. A distinct lineage ofCD4 Tcells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
14. Ivanov, I.I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006).
15. O'Shea, J.J. & Paul, W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102 (2010).
16. Pot, C. et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797-801 (2009).
17. Castellanos-Rubio, A., Santin, I., Irastorza, I., Castano, L., Carlos Vitoria, J. & Ramon Bilbao, J. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 42, 69-73 (2009).
18. Monteleone, I. et al. Characterization of IL-17A-producing cells in celiac disease mucosa. J. Immunol. 184, 2211-2218 (2010).
19. Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (2003).
20. Brand, S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: New immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58, 1152-1167 (2009).
21. Kabelitz, D. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19, 39-45 (2007).
22. Beitnes, A.C., Raki, M., Brottveit, M., Lundin, K.E., Jahnsen, F.L. & Sollid, L.M. Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge. PLoS One 7, e33556 (2012).
23. Fernandez, S. et al. Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am. J. Gastroenterol. 106, 528-538 (2011).
24. Nielsen, O.H., Kirman, I., Rudiger, N., Hendel, J. & Vainer, B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38, 180-185 (2003).
25. Korn, T.,Bettelli, E.,Oukka, M. &Kuchroo, V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
26. Alexopoulou, L., Holt, A.C., Medzhitov, R. & Flavell, R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738 (2001).
27. Kariko, K., Ni, H., Capodici, J., Lamphier, M. & Weissman, D. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279, 12542-12550 (2004).
28. Stene, L.C., Honeyman, M.C., Hoffenberg, E.J., Haas, J.E., Sokol, R.J. & Emery, L. et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: A longitudinal study. Am. J. Gastroenterol. 101, 2333-2340 (2006).
29. Siegel, M., Strnad, P., Watts, R.E., Choi, K., Jabri, B. & Omary, M.B. et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One 3, e1861 (2008).
30. Zhou, R., Wei, H., Sun, R., Zhang, J. & Tian, Z. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc. Natl. Acad. Sci.USA104, 7512-7515 (2007).
31. Allard, E.L. et al. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol 37, 3069-3077 (2007).
32. Linterman, M.A. et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207, 353-363 (2010).
33. Marsh, M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102, 330-354 (1992).
34. Cerf-Bensussan, N., Guy-Grand, D. & Griscelli, C. Intraepithelial lymphocytes of human gut: Isolation, characterisation and study of natural killer activity. Gut 26, 81-88 (1985).